Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3728

1.

Single cell transcriptome profiling of retinal ganglion cells identifies cellular subtypes.

Rheaume BA, Jereen A, Bolisetty M, Sajid MS, Yang Y, Renna K, Sun L, Robson P, Trakhtenberg EF.

Nat Commun. 2018 Jul 17;9(1):2759. doi: 10.1038/s41467-018-05134-3.

PMID:
30018341
2.

A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells.

Yang R, Browne JA, Eggener SE, Leir SH, Harris A.

Mol Hum Reprod. 2018 Jul 17. doi: 10.1093/molehr/gay029. [Epub ahead of print]

PMID:
30016502
3.

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub regulating granulo-monocytic fates.

Gu X, Ebrahem Q, Mahfouz RZ, Hasipek M, Enane F, Radivoyevitch T, Rapin N, Przychodzen B, Hu Z, Balusu R, Cotta CV, Wald D, Argueta C, Landesman Y, Martelli MP, Falini B, Carraway H, Porse BT, Maciejewski JP, Jha BK, Saunthararajah Y.

J Clin Invest. 2018 Jul 17. pii: 97117. doi: 10.1172/JCI97117. [Epub ahead of print]

4.

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.

Asada S, Goyama S, Inoue D, Shikata S, Takeda R, Fukushima T, Yonezawa T, Fujino T, Hayashi Y, Kawabata KC, Fukuyama T, Tanaka Y, Yokoyama A, Yamazaki S, Kozuka-Hata H, Oyama M, Kojima S, Kawazu M, Mano H, Kitamura T.

Nat Commun. 2018 Jul 16;9(1):2733. doi: 10.1038/s41467-018-05085-9.

5.

Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.

Zappasodi P, Marbello L, Borlenghi E, Fumagalli M, Bernardi M, Fracchiolla N, Mancini V, Da Vià M, Ravano E, Cerqui E, Ferretti VV, Rocca B, Calvello C, Cazzola M, Castagnola C, Rossi G.

Ann Hematol. 2018 Jul 15. doi: 10.1007/s00277-018-3424-4. [Epub ahead of print]

PMID:
30009341
6.

Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.

Hantel A, Stock W, Kosuri S.

Clin Lymphoma Myeloma Leuk. 2018 Jun 27. pii: S2152-2650(18)30480-4. doi: 10.1016/j.clml.2018.06.017. [Epub ahead of print] Review.

PMID:
30006258
7.

SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.

Baughn LB, Meredith MM, Oseth L, Smolarek TA, Hirsch B.

Cancer Genet. 2018 Oct;226-227:30-35. doi: 10.1016/j.cancergen.2018.05.004. Epub 2018 Jun 8.

PMID:
30005852
8.

Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.

Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, Jenkins H, Dai Y, Valentine M, Gu Z, Zhao Y, Zhang J, Payne-Turner D, Devidas M, Heerema NA, Carroll AJ, Raetz EA, Borowitz MJ, Wood BL, Mattano LA Jr, Maloney KW, Carroll WL, Loh ML, Willman CL, Gastier-Foster JM, Mullighan CG, Hunger SP.

Blood. 2018 Jul 11. pii: blood-2018-04-841676. doi: 10.1182/blood-2018-04-841676. [Epub ahead of print]

PMID:
29997224
9.

The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.

Gilmour J, Assi SA, Noailles L, Lichtinger M, Obier N, Bonifer C.

Sci Rep. 2018 Jul 10;8(1):10410. doi: 10.1038/s41598-018-28506-7.

10.

CBFβ-SMMHC Activates MYC Enhancers to Promote Leukemogenesis.

[No authors listed]

Cancer Discov. 2018 Jul 6. doi: 10.1158/2159-8290.CD-RW2018-113. [Epub ahead of print]

PMID:
29980511
11.

A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population.

Ying Y, Hong X, Xu X, Ma K, He J, Zhu F.

Vox Sang. 2018 Jul 5. doi: 10.1111/vox.12676. [Epub ahead of print]

PMID:
29978484
12.

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease.

Branford S, Wang P, Yeung DT, Thomson D, Purins A, Wadham C, Shahrin NH, Marum JE, Nataren N, Parker WT, Geoghegan J, Feng J, Shanmuganathan N, Mueller MC, Dietz C, Stangl D, Donaldson Z, Altamura H, Georgievski J, Braley J, Brown A, Hahn C, Walker I, Kim SH, Choi SY, Park SH, Kim DW, White DL, Yong ASM, Ross DM, Scott HS, Schreiber AW, Hughes TP.

Blood. 2018 Jul 2. pii: blood-2018-02-832253. doi: 10.1182/blood-2018-02-832253. [Epub ahead of print]

PMID:
29967129
13.

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.

Kuendgen A, Müller-Thomas C, Lauseker M, Haferlach T, Urbaniak P, Schroeder T, Brings C, Wulfert M, Meggendorfer M, Hildebrandt B, Betz B, Royer-Pokora B, Gattermann N, Haas R, Germing U, Götze KS.

Oncotarget. 2018 Jun 12;9(45):27882-27894. doi: 10.18632/oncotarget.25328. eCollection 2018 Jun 12. Review.

14.

Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.

Cheng Z, Dai Y, Pang Y, Jiao Y, Zhao H, Wu S, Zhang L, Zhang Y, Wang X, Wang L, Ma D, Qin T, Hu N, Zhang Y, Hu K, Zhang Q, Shi J, Fu L.

Cell Physiol Biochem. 2018 Jun 29;47(5):1853-1861. doi: 10.1159/000491065. [Epub ahead of print]

15.

CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Pulikkan JA, Hegde M, Ahmad HM, Belaghzal H, Illendula A, Yu J, O'Hagan K, Ou J, Muller-Tidow C, Wolfe SA, Zhu LJ, Dekker J, Bushweller JH, Castilla LH.

Cell. 2018 Jun 28;174(1):172-186.e21. doi: 10.1016/j.cell.2018.05.048.

PMID:
29958106
16.

Targeting transcription factors in acute myeloid leukemia.

Takei H, Kobayashi SS.

Int J Hematol. 2018 Jun 28. doi: 10.1007/s12185-018-2488-1. [Epub ahead of print] Review.

PMID:
29956082
17.

[Expression of CD19 and CD56 in AML Patients with RUNX1-RUNX1T1 Mutation and Its Clinical Significance].

Hu ZL, Zhang F, Huang BJ, Pan SJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):727-732. doi: 10.7534/j.issn.1009-2137.2018.03.016. Chinese.

PMID:
29950211
18.

[HER2 Expression in Childhood ETV6/RUNX1+ Acute Lymphoblastic Leukemia and Its Correlation with Clinical Features].

Sun CC, Chang LX, Zhu S, Liu C, Lan Y, Chen XY, Liu F, Chen YM, Zou Y, Zhu XF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):642-646. doi: 10.7534/j.issn.1009-2137.2018.03.002. Chinese.

PMID:
29950197
19.

Runx1 Role in Epithelial and Cancer Cell Proliferation Implicates Lipid Metabolism and Scd1 and Soat1 Activity.

Jain P, Nattakom M, Holowka D, Wang DH, Brenna JT, Ku AT, Nguyen H, Ibrahim S, Tumbar T.

Stem Cells. 2018 Jun 25. doi: 10.1002/stem.2868. [Epub ahead of print]

PMID:
29938858
20.

CSF3R mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.

Zhang Y, Wang F, Chen X, Zhang Y, Wang M, Liu H, Cao P, Ma X, Wang T, Zhang J, Zhang X, Lu P, Liu H.

Cancer. 2018 Jun 22. doi: 10.1002/cncr.31586. [Epub ahead of print]

PMID:
29932212

Supplemental Content

Loading ...
Support Center